Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease

Protein Expression and Purification

Volumn 16, Issue 2, 1999, Pages 347-354

  Mildner, Ana M ^a   Paddock, Donna J ^a   Lecureux, Lloyd W ^a   Leone, Joseph W ^a   Anderson, Donald C ^a   Tomasselli, Alfredo G ^a   Heinrikson, Robert L ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; CARBOXY TERMINAL HYDROLASE; CONNECTIVE TISSUE ACTIVATING PEPTIDE; ENZYME ACTIVITY; HYDROLYSIS; NEUTROPHIL ACTIVATING PEPTIDE 2; PROTEIN DIGESTION; PROTEINASE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033166214     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1999.1081     Document Type: Article

References (29)

1. Nilsson J., Stahl S., Lundeberg J., Uhlen, Nygren P-A. Affinity fusion strategies for detection, purification, and immobilization of recombinant proteins. Protein Express. Purif. 11:1997;1-16.
2. Baker R. T. Protein expression using ubiquitin fusion and cleavage. Curr. Opin. Biotechnol. 7:1996;541-546.
3. Baker R. T., Tobias J. W., Varshavsky A. Ubiquitin-specific proteases of Saccharomyces cereviseae. J. Biol. Chem. 267:1992;23364-23375.
4. Falquet L., Paquet N., Fruitger S., Hughes G. J., Hoang-Van K., Jaton J.-C. A human de-ubiquitinating enzyme with both isopeptidase and peptidase activities in vitro. FEBS Lett. 359:1995;73-77.
5. Woo S. K., Lee J. I., Park I. K., Yoo Y. J., Cho C. M., Kang M.-S., Ha D. B., Tanaka K., Chung C. H. Multiple ubiquitin C-terminal hydrolases from chick skeletal muscle. J. Biol. Chem. 270:1995;18766-18773.
6. Baek S. H., Choi K. S., Yoo Y. J., Cho J. M., Baker R. T., Tanaka K., Chung C. H. Molecular cloning of a novel ubiquitin-specific protease, UBP41, with isopeptidase activity in chick skeletal muscle. J. Biol. Chem. 272:1997;25560-25565.
7. Gilchrist C. A., Gray D. A., Baker R. T. A ubiquitin specific protease that efficiently cleaves the ubiquitin-proline bond. J. Biol. Chem. 272:1997;32280-32285.
8. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell. 79:1994;13-21.
9. Hochstrasser M. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol. 7:1995;215-223.
10. Ozkaynak E., Finley D., Solomon M. J., Varshavsky A. The yeast ubiquitin genes: a family of natural gene fusions. EMBO J. 6:1987;1429-1439.
11. Finley D., Bartel B., Varshavsky A. The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis. Science. 234:1986;179-186.
12. Redman K. L., Rechsteiner M. Identification of the long ubiquitin extension as ribosomal protein S27a. Nature. 338:1989;438-440.
13. Bachmair A., Finley D., Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Nature. 338:1986;394-401.
14. Miller H. I., Henzel W. J., Ridgway J. B., Kuang W. J., Chisholm V., Liu C-C. Cloning and expression of a yeast ubiquitin-protein cleaving activity in Escherichia coli. Biotechnology. 7:1989;698-704.
15. Tomasselli A. G., Mildner A. M., Paddock D. J., Wheeler J. S., Kubiak T. M., Martin R. A., Moseley W. M., Mott J. E., White M. C., Leone J. W., Heinrikson R. L. Use of the HIV-1 protease for excision of growth-hormone-releasing factor from synthetic and recombinant peptide precursors. Biotechnol. Appl. Biochem. 26:1997;39-49.
16. Tomasselli A. G., Heinrikson R. L. Specificity of HIV-1 proteases: An analysis of non-viral protein substrates. Methods Enzymol. Retroviral Proteases. 241:1994;279-301.
17. Tomasselli A. G., Sarcich J. L., Barrett L. J., Reardon I. M, Hui J. O., Evans D. B., Sharma S. K., Heinrikson R. L. Human immunodeficiency virus type-1 reverse transcriptase as a substrate of the viral protease. J. Protein Sci. 2:1993;2167-2176.
18. Mildner A. M., Rothrock D. J., Leone J. W., Bannow C. A., Lull J. M., Reardon I. M., Sarcich J. L., Howe W. J., Tomich C-S. C., Smith C. W., Heinrikson R. L., Tomasselli A. G. The HIV-1 protease as an enzyme and substrate: Mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties. Biochemistry. 33:1994;9405-9413.
19. Furie M. B., Randolph G. J. Chemokines and tissue injury. Am. J. Pathol. 146:1995;1287-1301.
20. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratoy Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
21. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-684.
22. Smith C. W., Hollars J. C., Patrick R. A., Hassett C. Motility and adhesiveness in human neutrophils: Effects of chemotatic factors. J. Clin. Invest. 63:1979;221-229.
23. Anderson D. C., Schmaistieg F. C., Arnaout M. A., Kohl S., Tosi M. F., Dana N., Buffone G. J., Hughes B. J., Brinkley B. R., Dickey W. D., Abramson J. S., Springer T., Boxer L. A., Hollers J. M., Smith C. W. Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP-138): Common relationship to diminished cell adherence. J. Clin. Invest. 74:1984;536-551.
24. Chou K-C, Tomasselli A. G., Reardon I. M., Heinrikson R. L. Prediction of HIV protease cleavage sites in proteins by a discriminant function method. Proteins: Struct. Funct. Genet. 24:1996;51-72.
25. Wilkinson K. D., Lee K. M., Deshpande S., Duerksen-Hughes P. J., Boss J. M., Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science. 246:1989;670-673.
26. Tobias J. W., Varshavsky A. Cloning and functional analysis of a ubiquitin-specific protease gene UBP1 of Saccharomyces cerevisiae. J. Biol. Chem. 266:1991;12021-12028.
27. Proudfoot A. E. I., Peitsch M. C., Power C. A., Allet B., Mermod J-J., Bacon K., Wells T. N. C. Structure and bioactivity of recombinant human CTAP-III and NAP-2. J. Protein Chem. 16:1997;37-49.
28. Malkowski M. G., Wu J. Y., Lazar J. B., Johnson P. H., Edwards B. F. P. The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution. J. Biol. Chem. 270:1995;7077-7087.
29. Ehlert J. E., Petersen F., Kubbutat M. H. G., Gerdes J., Flad H-D., Brandt E. Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). J. Biol. Chem. 270:1995;6338-6344.